How is institutional ownership of VVOS changing?

VVOS institutional ownership fell by 9.30 percentage points quarter-over-quarter, with a net change of -2 holders.

How concentrated is VVOS ownership among the top holders?

The top 10 institutions account for 85.7% of all reported 13F value in VVOS, and the top 25 account for 100.0%.

Where does this VVOS institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

Vivos Therapeutics, Inc. (VVOS) Institutional Ownership Q2 2026 | Top 13F Holders

✨

Institutional ownership decreased this quarter (-9.30 pp), while top 10 holders maintain a highly concentrated 85.7% of value.

Institutional Ownership3.8%$243K total value · ▼ 9.30 pp vs prior quarter

Smart Money Score26 / 100Bearish

Institutions & Flow22 holders-3 net flow (+1 / -4)

AI Insights & Key Takeaways

Negative Institutional Flow (-3)
Susquehanna International Group, Llp maintains a significant position
Top 10 holders control 85.7% of institutional value
No Insider Signal

Top Institutional Holders of VVOS

Ranked by reported Q2 2026 13F market value

Top 10 Holders

85.7%

Top 25 Holders

100.0%

Share of total reported institutional value in VVOS held by the largest 10 / 25 filers.

#	Institution	Shares Held	Market Value	QoQ Change	Ownership %	% of Fund
1	GEODE CAPITAL MANAGEMENT, LLC	85K	$39K	-11.0%	0.612%	0.00%
2	IHT Wealth Management, LLC	77K	$35K	+86.9%	0.552%	0.00%
3	VANGUARD CAPITAL MANAGEMENT LLC	61K	$28K	-77.8%	0.436%

Quarterly Institutional Activity

Filings activity in VVOS during Q2 2026, grouped by how each filer changed its position.

New Buyers

Institutions that opened a new VVOS position in Q2 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP

VVOS Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

Quarter	Inst. Holders	Δ Holders	Ownership %	Δ Ownership	Total 13F Value	Δ Value
Q2 2026	22	8.3%	3.82%	9.30 pp	$0M	89%
Q1 2026	24	+33%	13.12%	+7.45 pp	$2M	+95%
Q4 2025	18	18%	5.67%	1.91 pp	$1M	41%
Q3 2025	22	+16%	7.58%	+2.26 pp	$2M	+65%
Q2 2025	19	14%	5.32%	+1.55 pp	$1M	35%
Q1 2025	22	+10%

VVOS — Frequently Asked Questions

Quick answers to the most common questions about buying VVOS stock.

What percentage of VVOS is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Vivos Therapeutics, Inc. stands at 3.8%, held across 22 reporting institutions.

Who is the largest institutional holder of VVOS?

GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of VVOS, with approximately 85,001 shares worth $0.00B as of Q2 2026.

Is VVOS a hedge fund favorite?

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of VVOS, including SUSQUEHANNA INTERNATIONAL GROUP, LLP.

What is VVOS's Smart Money Score?

Our composite Smart Money Score for VVOS is 26 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought VVOS this quarter?

Vivos Therapeutics, Inc. (VVOS) Institutional Ownership

AI Insights & Key Takeaways

Top Institutional Holders of VVOS

Quarterly Institutional Activity

New Buyers

VVOS Institutional Ownership by Quarter

Exited Positions